Planning

The Provision of Intravenous Therapy and Bisphosphonates Service on behalf of NHS Greater Manchester Integrated Care Board (GM ICB).

  • NHS SHARED BUSINESS SERVICES LIMITED

F01: Prior information notice (prior information only)

Notice identifier: 2025/S 000-000448

Procurement identifier (OCID): ocds-h6vhtk-04ce17

Published 8 January 2025, 10:28am



Section one: Contracting authority

one.1) Name and addresses

NHS SHARED BUSINESS SERVICES LIMITED

Spectrum House

BRISTOL

BS13LG

Contact

Sarah Golby

Email

sarah.golby1@nhs.net

Country

United Kingdom

Region code

UKK11 - Bristol, City of

Companies House

05280446

Internet address(es)

Main address

https://www.sbs.nhs.uk/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://s1-eu.ariba.com/Sourcing/Main/ad/login/SSOActions?awr=1&realm=NHS-SBS

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Other type

Joint venture between the Department of health and Sopra Steria

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

The Provision of Intravenous Therapy and Bisphosphonates Service on behalf of NHS Greater Manchester Integrated Care Board (GM ICB).

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS Greater Manchester Integrated Care Board (NHS GM ICB) is currently developing their Service Specification, contracting process and commercial model for The Provision of Intravenous Therapy including Bisphosphonates Service.

This Market Engagement Questionnaire (MEQ) seeks the views and opinions on the proposed delivery model of those organisations that may be interested in delivering the Service.

The MEQ can be found on SAP Ariba at the below link:

https://discovery.ariba.com/rfx/21473877

two.1.5) Estimated total value

Value excluding VAT: £527,363.47

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKD3 - Greater Manchester

two.2.4) Description of the procurement

NHS Greater Manchester Integrated Care Board (NHS GM ICB) is currently developing their Service Specification, contracting process and commercial model for The Provision of Intravenous Therapy including Bisphosphonates Service.

This Market Engagement Questionnaire (MEQ) seeks the views and opinions on the proposed delivery model of those organisations that may be interested in delivering the Service.

two.3) Estimated date of publication of contract notice

3 March 2025


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes